Back to Miscellaneous News
Edwards Wildman Welcomes Intellectual Property Partner Bryan Zerhusen in Hartford
Monday, January 06, 2014
Edwards Wildman Palmer LLP is pleased to announce that Bryan D. Zerhusen, Ph.D., has joined the firm as a partner in its Intellectual Property Department. Zerhusen, who will base his practice in the firm’s Hartford office, focuses on all aspects of domestic and foreign patent preparation, prosecution, and counseling for companies in the healthcare, chemical, and life sciences industries.
Zerhusen counsels clients in all areas of molecular biology, biochemistry, and biotechnology. He brings a wealth of experience in patent preparation and prosecution, strategic portfolio management, patentability and freedom-to-operate opinions, licensing, due diligence investigations and reexamination proceedings. His clients include solo inventors, start-up and early stage companies, academic institutions, foreign law firms, as well as global corporations in the medical biotechnology, agricultural biotechnology, diagnostic, chemical, pharmaceutical, and medical science sectors. An inventor, Zerhusen, holds several patents relating to biopharmaceutical inventions.
“Bryan’s impressive scientific background, coupled with his formidable patent knowledge, will be an ideal complement to our global intellectual property practice,” said Scott Wofsy, co-chair of Edwards Wildman’s Intellectual Property Department. “He is at the forefront of cutting-edge medical research, and his extensive experience in patent counseling will be a tremendous asset to our life sciences, biotechnology, and pharmaceutical clients.”
Previously, Zerhusen was a Hartford-based partner in McCarter & English’s Intellectual Property / Information Technology group, where he helped to establish and grow the life sciences practice. Before joining McCarter & English, Zerhusen was a research scientist at CuraGen Corporation, where he focused on drug discovery, proteomics, and genomics. Zerhusen also held a post-doctoral fellowship, in which he concentrated on the molecular and physiological origins of cystic fibrosis. As a research scientist, Zerhusen’s work resulted in the filing of over 200 patent applications claiming various novel therapeutics, including genes, proteins, and antibodies.
Zerhusen has served as a board member of the MIT Enterprise Forum of Connecticut, Inc. In addition, he is a member of the American Bar Association, the Association of University Technology Managers, and the American Intellectual Property Law Association.
Zerhusen earned his law degree from Quinnipiac University School of Law; his Ph.D. in cell physiology from Case Western Reserve University School of Medicine; and his undergraduate degree in zoology from Miami University in Ohio.
Edwards Wildman is a full-service, international law firm with 600 lawyers in the US, Europe and Asia. We have market-leading capabilities in private equity and venture capital, complex litigation, insurance and reinsurance, IP and technology, and corporate and public finance. We have more than a century of experience as business-minded legal counsel. We share our clients' entrepreneurial spirit and understand their industries, and we succeed because we add value to our clients’ business. We have offices in Boston, Chicago, Hartford, Hong Kong, Istanbul, London, Los Angeles, Morristown (NJ), Miami, New York, Orange County, Providence, Stamford, Tokyo, Washington, DC, and West Palm Beach.
Back to Miscellaneous News